EcoDrugPlus

Phosphodiesterase 7a

Ensembl ID : ENSCHAG00000017472
Gene Symbol: PDE7A
1 Cross references
215 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSCHAG00000020119
Gene Symbol: PDE7B
1 Cross references
174 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSCHAG00000025292
Gene Symbol: PIK3R2
3 Cross references
191 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSCHAG00000015117
Gene Symbol: PIK3R2
3 Cross references
190 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSCHAG00000019432
Gene Symbol: PIK3R3
1 Cross references
188 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSCHAG00000017547
Gene Symbol: PIK3R5
1 Cross references
202 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 1 (Alpha)

Ensembl ID : ENSCHAG00000025810
Gene Symbol: PIK3R1
1 Cross references
253 Possible Orthologues:

Phospholipase A2 Group X

Ensembl ID : ENSCHAG00000013463
Gene Symbol: PLA2G10
1 Cross references
230 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase, Phosphoribosylglycinamide Synthetase, Phosphoribosylaminoimidazole Synthetase

Ensembl ID : ENSCHAG00000023964
Gene Symbol: GART
3 Cross references
214 Possible Orthologues:

Plasma Kallikrein-Like

Ensembl ID : ENSCHAG00000018637
Gene Symbol: LOC105910278
2 Cross references
214 Possible Orthologues:

Platelet Activating Factor Receptor

Ensembl ID : ENSCHAG00000027746
Gene Symbol: PTAFR
3 Cross references
224 Possible Orthologues:

Platelet-Activating Factor Acetylhydrolase-Like

Ensembl ID : ENSCHAG00000002750
Gene Symbol: LOC105894475
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).